Axsome Therapeutics (AXSM) Misses Q1 EPS by 93c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($1.03), $0.93 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Axsome Therapeutics (AXSM) PT Raised to $316 at Mizuho
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Axsome Therapeutics (AXSM) PT Raised to $275 at Guggenheim